Tag Archives: conferences

27th Annual BTLJ-BCLT Symposium: From the DMCA to the DSA: Keynote and copyright interactions

Opening Keynote by Irene Roche-Laguna of the European Commission’s DGCONNECT group on origins and aspirations for the DSA People thought it couldn’t be done; didn’t know whether it would be a directive or a regulation. But took only 6 months … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

27th Annual BTLJ-BCLT Symposium: From the DMCA to the DSA—A Transatlantic Dialogue on Online Platform Liability and Copyright Law

Tutorial “The EU Digital Services Act – Overview and Central Features” General DSA Architecture and Approach      Martin Senftleben, University of Amsterdam Formally, the safe harbor system is still in place for mere conduit, caching and hosting services for third-party information … Continue reading

Posted in Uncategorized | Tagged , , | Leave a comment

Protecting Creativity with a Bottle of Jack on the Floribama Shore (and tiny JDI oral argument observations)

Media Law Resource Center conference, Southwestern Law School Kevin Vick, Jassy Vick Carolan LLP (Moderator) Just a few panel notes since I’m not going to recap Rogers or MFGB v. Viacom. Evynne Grover, Vice President, Media Liability Claims Practice Leader, … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

Panel on Jack Daniels argument at AU-WCL, March 22

 IP at the Supreme Court Series: Jack Daniel’s Properties, Inc. v. VIP Products LLC March 22 | 5:00 – 6:30pm EDT | Hybrid | NT01 | Reception to FollowRegistration Required Moderated by Professor Christine Farley American University Washington College of Law regularly … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

Fourteenth Trademark Scholars’ Roundtable, part 3 (Evidence)

Changes in Trademark Law and Evidentiary Rules Introduction:   Jake Linford Before courts admitted surveys routinely, they were concerned about hearsay. Sometimes rejecting surveys seems like judicial notice—“cola” as generic; the court doesn’t want to hear contrary survey evidence. Some objections … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

Fourteenth Trademark Scholars Roundtable, part 2

 Session 2:        Responding to Anachronisms Introduction:   Mike Grynberg VIP may tell us a lot about what the potentials are. Incrementalism: read Lanham Act along with other things like its common law foundations and First Amendment principles—not empty formalism; recognize normative … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

Fourteenth Trademark Scholars’ Roundtable: Are Key Trademark and Unfair Competition Doctrines Anachronistic?

UCLA School of Law Mark Janis: 1st day of TM: students’ experience of brands as used by owners & 3rd parties is so disconnected from the historical traditions of TM. Anachronism may give away too much by suggesting the cause … Continue reading

Posted in Uncategorized | Tagged , | Leave a comment

WIPIP SESSION 8.A. — IP Theory (partial)

Ester van Zimmeren, University of Antwerp Exploring Trust Building Mechanisms for Specialized Intellectual Property Courts CJEU patent court hasn’t entered into force, but there are local and regional bodies. Question: will users trust a new court? Trust in the court … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment

WIPIP SESSION 6.A. Competition and Antitrust

BJ Ard, University of Wisconsin Law School Competition With and Without IP in the Video Game Industry Negative space; a number of lessons. Character protection is meaningful: Pac-Man/combination of elements. Patents can cover some elements/game rules, but most gameplay won’t … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment

FDA/FTC Workshop on a Competitive Marketplace for Biosimilars

FDA Licensure Process and U.S. Biosimilar Markets   [I entered in media res] · Eva Temkin, Acting Director for Policy, Office of Therapeutic Biologics and Biosimilars,  CDER, FDA   · Christine Simmon, Executive Director, Biosimilars Council, AAM: barriers to entry for … Continue reading

Posted in Uncategorized | Tagged , , , , | Leave a comment